Ambrosia Biosciences
Latest round
- Series B
Last raised
- Mar 2026
Total raised
- $116M
Investors
- 8
About Ambrosia Biosciences
Based in Colorado, US, and founded in 2024, Ambrosia Biosciences Inc. operates as a biotechnology company that offers drugs. The company was founded by its president, Nick Traggis. The company founded by Nick Traggis. In March 2026, Ambrosia Biosciences Inc. Ambrosia Biosciences develops small molecule-based therapies for obesity and other metabolic disorders.
Who invested in Ambrosia Biosciences
8 investors across 2 rounds
See all investors in Ambrosia Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Ambrosia Biosciences
Who invested in Ambrosia Biosciences?
Ambrosia Biosciences has 8 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ambrosia Biosciences raised?
Ambrosia Biosciences has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Ambrosia Biosciences last raise money?
Ambrosia Biosciences's most recent round on record is a Series B, in Mar 2026.
What does Ambrosia Biosciences do?
Based in Colorado, US, and founded in 2024, Ambrosia Biosciences Inc.
Where is Ambrosia Biosciences headquartered?
Ambrosia Biosciences is headquartered in Boulder, US.
Which VCs invest in companies like Ambrosia Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ambrosia Biosciences's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Ambrosia Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.